Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis

BACKGROUND: We conducted a systematic review and meta-analysis to evaluate outcomes following chimeric antigen receptor T cell (CAR-T) therapy in relapsed/refractory acute myeloid leukemia (RR-AML). METHODS: We performed a literature search on PubMed, Cochrane Library, and Clinicaltrials.gov. After...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahzad, Moazzam, Nguyen, Andrea, Hussain, Ali, Ammad-Ud-Din, Mohammad, Faisal, Muhammad Salman, Tariq, Ezza, Ali, Fatima, Butt, Atif, Anwar, Iqra, Chaudhary, Sibgha Gull, Lutfi, Forat, Ahmed, Nausheen, Singh, Anurag K., Hematti, Peiman, McGuirk, Joseph P., Mushtaq, Muhammad Umair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164930/
https://www.ncbi.nlm.nih.gov/pubmed/37168849
http://dx.doi.org/10.3389/fimmu.2023.1152457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164930/
https://www.ncbi.nlm.nih.gov/pubmed/37168849
http://dx.doi.org/10.3389/fimmu.2023.1152457

Ejemplares similares